CSF monoamine metabolites in child and adult psychiatric patients. A developmental perspective.

Concentrations of acid metabolites of dopamine and serotonin were measured in lumbar CSF of a diagnostically heterogeneous group of 154 psychiatric patients following oral probenecid loading. The patients ranged in age from 2 to 67 years old. No patients had received psychoactive medications for at least two weeks prior to the lumbar puncture. Children had higher mean CSF homovenillic acid (HVA) levels, higher mean CSF HVA-probenecid ratios, higher CSF HVA-log probenecid ratios, and lower mean CSF probenecid levels than adults. Age was negatively correlated with CSF HVA level and with CSF HVA-probenecid ratio. These correlations were more pronounced in male patients than in female patients.

[1]  R. Roth,et al.  PLASMA AND CSF DOPAMINE METABOLITES IN PSYCHIATRIC PATIENTS: EFFECTS OF PROBENECID AND HALOPERIDOL , 1979 .

[2]  B. Shaywitz,et al.  Chronic, multiple tics of Gilles de la Tourette's disease. CSF acid monoamine metabolites after probenecid administration. , 1978, Archives of general psychiatry.

[3]  B. Shaywitz,et al.  Dopamine and serotonin metabolism in neuropsychiatrically disturbed children. CSF homovanillic acid and 5-hydroxyindoleacetic acid. , 1977, Archives of general psychiatry.

[4]  J. Maas.  The effects of psychopharmacological agents on central nervous system amine metabolism in man. , 1977, Annual review of pharmacology and toxicology.

[5]  G. Heninger,et al.  CSF amine metabolites, clinical symptoms, and body movement in psychiatric patients. , 1976, Biological psychiatry.

[6]  B. Shaywitz,et al.  Reduced cerebrospinal fluid 5‐hydroxyindoleacetic acid and homovanillic acid in children with epilepsy , 1975, Neurology.

[7]  Prange Aj,et al.  Behavioral effects of thyrotropin releasing hormone in animals and man: a generic hypothesis. , 1975 .

[8]  Post Rm,et al.  Studies of amine metabolites in affective illness and in schizophrenia: a comparative analysis. , 1975 .

[9]  B. Shaywitz,et al.  Biogenic amines in autistic and atypical children. Cerebrospinal fluid measures of homovanillic acid and 5-hydroxyindoleacetic acid. , 1974, Archives of general psychiatry.

[10]  S. Young,et al.  Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies. , 1974, Brain research.

[11]  M. Bowers.  LUMBAR CSF 5- HYDROXYINDOLEACETIC ACID AND HOMOVANILLIC ACID IN AFFECTIVE SYNDROMES , 1974, The Journal of nervous and mental disease.

[12]  J. Korf,et al.  Cerebral monoamines and depression. An investigation with the Probenecid technique. , 1973, Archives of general psychiatry.

[13]  F. Goodwin,et al.  Psychomotor activity and cerebrospinal fluid amine metabolites in affective illness. , 1973, The American journal of psychiatry.

[14]  F. Goodwin,et al.  Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique. , 1973, The American journal of psychiatry.

[15]  J. Meek,et al.  Acidic and neutral metabolites of norepinephrine: their metabolism and transport from brain. , 1972, The Journal of pharmacology and experimental therapeutics.

[16]  G. Breese,et al.  Developmental characteristics of brain catecholamines and tyrosine hydroxylase in the rat: effects of 6‐hydroxydopamine , 1972, British journal of pharmacology.

[17]  M. Bowers.  Clinical measurements of central dopamine and 5-hydroxytryptamine metabolism: reliability and interpretation of cerebrospinal fluid acid monoamine metabolite measures. , 1972, Neuropharmacology.

[18]  J. Korf,et al.  Amine metabolism in the human brain: further evaluation of the probenecid test. , 1971, Brain research.

[19]  A. Brun,et al.  STUDIES OF THE MONOAMINE METABOLISM IN THE CENTRAL NERVOUS SYSTEM IN JAKOB‐CREUTZFELDT DISEASE , 1971, Acta neurologica Scandinavica.

[20]  J. Brody,et al.  Parkinsonism-dementia and amyotrophic lateral sclerosis of Guam. Effect of probenecid on monoamine catabolite levels in cerebrospinal fluid. , 1971, Archives of neurology.

[21]  V. Dubowitz,et al.  5‐Hydroxyindoles in Hydrocephalus. A Comparative Study of Cerebrospinal Fluid and Blood Levels , 1970, Developmental medicine and child neurology.

[22]  J. Korf,et al.  5-Hydroxyindoleacetic Acid Levels in the Cerebrospinal Fluid of Depressive Patients treated with Probenecid , 1970, Nature.

[23]  B. Roos,et al.  5‐HYDROXYINDOLEACETIC ACID IN CEREBROSPINAL FLUID OF HYDROCEPHALIC CHILDREN , 1969, Acta paediatrica Scandinavica.

[24]  B. Campbell,et al.  Ontogeny of Adrenergic Arousal and Cholinergic Inhibitory Mechanisms in the Rat , 1969, Science.

[25]  G. Heninger,et al.  Cerebrospinal fluid 5-hydroxyindoleactiic acid and homovanillic acid in psychiatric patients. , 1969, International journal of neuropharmacology.

[26]  M. Bowers,et al.  Relationship of Monoamine Metabolites in Human Cerebrospinal Fluid to Age , 1968, Nature.

[27]  B. Roos,et al.  Concentrations of 5-Hydroxyindole-acetic Acid and Homovanillic Acid in the Cerebrospinal Fluid after Treatment with Probenecid in Patients with Parkinson's Disease , 1968, Nature.

[28]  B. Brodie,et al.  Application of seady-state kinetics to studies of the transfer of 5-hydroxyindoleacetic acid from brain to plasma. , 1967, The Journal of pharmacology and experimental therapeutics.

[29]  H. Agrawal,et al.  Changes in monoamines of rat brain during postnatal ontogeny. , 1966, Biochimica et biophysica acta.

[30]  J. B. Stanton,et al.  5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases. , 1966, Lancet.